Carla Iarlori

1.4k total citations
18 papers, 1.2k citations indexed

About

Carla Iarlori is a scholar working on Physiology, Pharmacology and Neurology. According to data from OpenAlex, Carla Iarlori has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Pharmacology and 6 papers in Neurology. Recurrent topics in Carla Iarlori's work include Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Carla Iarlori is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Carla Iarlori collaborates with scholars based in Italy and United States. Carla Iarlori's co-authors include D. Gambi, Marcella Reale, Bernardo Perfetti, Astrid Thomas, Marco Onofrj, Marta Di Nicola, Claudio Feliciani, Francesco Gambi, Giovanna De Luca and Alessandra Lugaresi and has published in prestigious journals such as Neuropharmacology, Brain Behavior and Immunity and Journal of Alzheimer s Disease.

In The Last Decade

Carla Iarlori

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla Iarlori Italy 16 532 378 305 294 204 18 1.2k
Tony Heurtaux Luxembourg 16 675 1.3× 350 0.9× 202 0.7× 482 1.6× 203 1.0× 30 1.3k
Vitaliy Gavrilyuk United States 17 559 1.1× 452 1.2× 122 0.4× 659 2.2× 336 1.6× 22 1.5k
Melissa Freeman United States 13 515 1.0× 910 2.4× 199 0.7× 421 1.4× 178 0.9× 21 1.5k
Kaifu Ke China 22 285 0.5× 248 0.7× 257 0.8× 628 2.1× 169 0.8× 72 1.3k
Rob Veerhuis Netherlands 12 343 0.6× 414 1.1× 132 0.4× 284 1.0× 68 0.3× 15 970
Robert E. Mrak United States 8 733 1.4× 777 2.1× 118 0.4× 479 1.6× 187 0.9× 9 1.4k
Palwinder K. Mander United Kingdom 14 697 1.3× 314 0.8× 178 0.6× 491 1.7× 290 1.4× 20 1.6k
Anna Piotrowska Poland 25 262 0.5× 883 2.3× 284 0.9× 289 1.0× 572 2.8× 42 1.4k
Audrey N. Kalehua United States 14 754 1.4× 257 0.7× 139 0.5× 275 0.9× 336 1.6× 15 1.2k
Ren‐Hong Du China 17 449 0.8× 184 0.5× 348 1.1× 592 2.0× 415 2.0× 23 1.5k

Countries citing papers authored by Carla Iarlori

Since Specialization
Citations

This map shows the geographic impact of Carla Iarlori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Iarlori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Iarlori more than expected).

Fields of papers citing papers by Carla Iarlori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Iarlori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Iarlori. The network helps show where Carla Iarlori may publish in the future.

Co-authorship network of co-authors of Carla Iarlori

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Iarlori. A scholar is included among the top collaborators of Carla Iarlori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Iarlori. Carla Iarlori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Iarlori, Carla. (2009). Anti-Inflammatory Agents in Parkinsons Disease. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 8(1). 72–84. 1 indexed citations
2.
Reale, Marcella, Carla Iarlori, Astrid Thomas, et al.. (2008). Peripheral cytokines profile in Parkinson’s disease. Brain Behavior and Immunity. 23(1). 55–63. 412 indexed citations
3.
Reale, Marcella, Carla Iarlori, Claudio Feliciani, & D. Gambi. (2008). Peripheral Chemokine Receptors, Their Ligands, Cytokines and Alzheimer's Disease. Journal of Alzheimer s Disease. 14(2). 147–159. 92 indexed citations
4.
Iarlori, Carla, D. Gambi, Alessandra Lugaresi, et al.. (2008). Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone®). Multiple Sclerosis Journal. 14(6). 739–748. 35 indexed citations
5.
Reale, Marcella, et al.. (2006). The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Neuropharmacology. 50(5). 606–613. 46 indexed citations
6.
Iarlori, Carla, D. Gambi, Francesco Gambi, et al.. (2005). Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease. Experimental Gerontology. 40(7). 605–611. 39 indexed citations
7.
Reale, Marcella, et al.. (2005). Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1? and interleukin-6 release from lymphocytes of Alzheimer's disease patients. Experimental Gerontology. 40(3). 165–171. 82 indexed citations
8.
Gambi, Francesco, Marcella Reale, Carla Iarlori, et al.. (2004). Alzheimer Patients Treated With an AchE Inhibitor Show Higher IL-4 and Lower IL-1β Levels and Expression in Peripheral Blood Mononuclear Cells. Journal of Clinical Psychopharmacology. 24(3). 314–321. 49 indexed citations
9.
Lugaresi, Alessandra, Angelo Di Iorio, Carla Iarlori, et al.. (2004). IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors. Experimental Gerontology. 39(4). 653–657. 26 indexed citations
10.
Reale, Marcella, Carla Iarlori, Francesco Gambi, et al.. (2004). Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. Journal of Neuroimmunology. 148(1-2). 162–171. 100 indexed citations
11.
Muraro, Paolo A., Laura Bonanni, Andrea Pantalone, et al.. (2004). Decreased integrin gene expression in patients with MS responding to interferon-β treatment. Journal of Neuroimmunology. 150(1-2). 123–131. 34 indexed citations
12.
Iarlori, Carla, Marcella Reale, Giovanna De Luca, et al.. (2002). Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis. Journal of Neuroimmunology. 123(1-2). 170–179. 24 indexed citations
13.
Paganelli, Roberto, Angelo Di Iorio, Eleonora Sparvieri, et al.. (2002). Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild–moderate Alzheimer's disease patients. Experimental Gerontology. 37(2-3). 257–263. 106 indexed citations
14.
Lugaresi, Alessandra, Christina M. Caporale, D. Farina, et al.. (2001). Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis. Neurological Sciences. 22(2). 209–210. 20 indexed citations
15.
Iarlori, Carla, Marcella Reale, Alessandra Lugaresi, et al.. (2000). RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b. Journal of Neuroimmunology. 107(1). 100–107. 51 indexed citations
16.
Luca, Giovanna De, Alessandra Lugaresi, Carla Iarlori, et al.. (1999). Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. Journal of Neuroimmunology. 95(1-2). 190–194. 31 indexed citations
17.
Luca, Giovanna De, et al.. (1998). Interferon beta normalizes suppressor cell function in dysimmune neuropathies. Journal of Neuroimmunology. 82(1). 1–4. 19 indexed citations
18.
DeLuca, Gabriele C., Marcella Reale, Carla Iarlori, et al.. (1998). RANTES and MCP-1 secretion by mononuclear cells of patients with multiple sclerosis. Journal of Neuroimmunology. 90(1). 71–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tony Heurtaux Breakdown of academic impact, for papers by Vitaliy Gavrilyuk Breakdown of academic impact, for papers by Melissa Freeman Breakdown of academic impact, for papers by Kaifu Ke Breakdown of academic impact, for papers by Rob Veerhuis Breakdown of academic impact, for papers by Robert E. Mrak Breakdown of academic impact, for papers by Palwinder K. Mander Breakdown of academic impact, for papers by Anna Piotrowska Breakdown of academic impact, for papers by Audrey N. Kalehua Breakdown of academic impact, for papers by Ren‐Hong Du
Rankless by CCL
2026